Day 2

LEVANT 2: Initial results from the new drug eluting balloon for femoropopliteal lesions

solaci
solaci
421
0

This prospective multicenter study randomized 476 patients 2:1 to paclitaxel eluting balloon versus conventional balloon for femoropopliteal region lesions with the primary objective of assessing death, free amputationsurvival and reintervention at 6 months. At 6 months follow-up a higher rate of restenosis with conventional balloon was observed.These are preliminary results and we must wait for a longer term results.

6_kenneth_rosenfield
Kenneth Rosenfield | Prof. Dierk Scheinert
2013-10-30

Original title: LEVANT 2: A Prospective, Randomized Trial of a Paclitaxel-Coated Balloon vs. Standard Balloon Angioplasty in Diseased Femoropopliteal Arteries

Previous article
Exclusive Interview with Dr. Henrique Ribeiro on his article: coronary obstruction after TAVI
Next article
RIBS V: Pharmacological balloon vs second-generation drug-eluting stent in the treatment of BMS restenosis
solaci
solaci

More articles by this author

ADVISE II: iFFR comparable toFFRbut with out adenosine

solaci - 0
Several studies tested the utility of fractional flow reserve (FFR) to assess coronary lesions functionally. The FFR required for its measurement amaximum hyperemia that...

CHILL-MI: Hypothermia fails to show benefit in patients with acute ST- elevation IAM.

solaci - 0
Hypothermia improves myocardial ischemia in animals but studies in humans failed to demonstrate benefit to that extent.We admitted 120 patients experiencing anterior-posterior STEMI with...

SMART-CASE: Angiographic Guidanceangioplastyto >50% versus >70% lesions.

solaci - 0
This prospective randomized study compared aggressive revascularization angiography injuries 50% versus a most conservative revascularization lesions>70%.The primary end point was death, myocardial infarction and...

RIBS V: Pharmacological balloon vs second-generation drug-eluting stent in the treatment of BMS restenosis

solaci - 0
The ideal therapy for treating in-stent restenosis continues to be debated . The pharmacological balloons showed good results in this context, but no direct...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Day 2

ADVISE II: iFFR comparable toFFRbut with out adenosine

Several studies tested the utility of fractional flow reserve (FFR) to assess coronary lesions functionally. The FFR required for its...
solaci -
SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Dr. Juan Manuel Pérez - 0
Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Dr. Juan Manuel Pérez - 0
Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Dr. Juan Manuel Pérez - 0
Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...